BMC Infectious Diseases Volume 8
|
Viewing options:Associated material:Related literature:- Articles citing this article
- Other articles by authors
- Related articles/pages
Tools:Post to:
|
Research articlePediatric campylobacteriosis in northern Taiwan from 2003 to 2005Ji-Rong Yang1 , Ho-Sheng Wu1,2 , Chuen-Sheue Chiang1,3 and Jung-Jung Mu1  1Research and Diagnostic Center, Centers for Disease Control, Department of Health, Taipei, Taiwan 2School of Medical Laboratory Science and Biotechnology, Taipei Medical University, Taipei, Taiwan 3Center of General Education, National Taipei College of Nursing, Taipei, Taiwan author email corresponding author email
BMC Infectious Diseases 2008,
8:151doi:10.1186/1471-2334-8-151
|
|
| Published: |
31 October 2008 |
Abstract
Background
There has been a marked increase in the incidence of, and concern regarding, human Campylobacter jejuni and C. coli infections worldwide during the last decade. As the highest infectious disease control apparatus in Taiwan, we aimed to describe the character of Campylobacter isolates from infected children, as well as basic information about the patients, from December 2003 to February 2005.
Methods
A total of 894 fecal specimens were collected by several clinics and hospitals from children who had diarrhea, followed by plating onto selective media. Drug susceptibility test of the isolates from these specimens were conducted by disc diffusion method and their serotypes were also studied using commercial antisera made in Japan.
Results
The isolation rate of Campylobacter during these 15 months was 6.8% and was higher in winter (11.1%) than in other seasons. C. jejuni was the most prevalent (95.1%) species in northern Taiwan, comparable to other developed countries. Among the 61 Campylobacter isolates, most were resistant to tetracycline (93.4%), nalidixic acid (91.8%), ciprofloxacin (90.2%), and ampicillin (85.5%). Erythromycin-resistant isolates represented 3.3% of all isolates, suggesting that this drug may be the first choice for treatment. The serotypes of the 61 isolates were demonstrated and only 41.4% were typable.
Conclusion
In this study, the Taiwan CDC provided an epidemiological analysis of Campylobacter infection, including the isolation rate, age, seasonal distribution, antimicrobial drug susceptibility patterns, and serotypes of the isolates from pediatric patients in northern Taiwan from 2003 to 2005. |